[Ed. – Advocacy groups and media shrieked like banshees that policy norms were being violated when Trump made similar judgments (most of which were actually less sweeping and arbitrary) about previous presidential edicts.]
President Joe Biden’s United States Department of Health and Human Services (HHS) on Thursday stopped executive orders from his predecessor designed to significantly lower prescription drug prices for Americans, including insulin and epinephrine.
The new administration will apparently re-evaluate the executive action from President Donald Trump toward the end of March. It remains unclear if it will be reinstated. …
“This freeze is part of the Biden administration’s large-scale effort announced this week that will scrutinize the Trump administration’s health policies,” the report noted. “If the previous administration’s policies raise ‘fact, law, or policy’ concerns, the Biden HHS will delay them and consult with the Office of Management and Budget about other actions.”
Trending: Cartoon of the Day: Blind trust